Dynavax Technologies | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Adma Biologics USD 331.41M 13.22M 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Dynavax Technologies USD 815.97M 32.97M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Merck USD 35.5B 3.28B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
TG Therapeutics USD 566.36M 7.71M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Dynavax Technologies Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.